about
Avian Reoviruses Cause Apoptosis in Cultured Cells: Viral Uncoating, but Not Viral Gene Expression, Is Required for Apoptosis InductionCrystal Structure of the Avian Reovirus Inner Capsid Protein AA versatile molecular tagging method for targeting proteins to avian reovirus muNS inclusions. Use in protein immobilization and purificationIC-tagging and protein relocation to ARV muNS inclusions: a method to study protein-protein interactions in the cytoplasm or nucleus of living cellsStructure of the carboxy-terminal receptor-binding domain of avian reovirus fibre sigmaC.Avian reovirus morphogenesis occurs within viral factories and begins with the selective recruitment of sigmaNS and lambdaA to microNS inclusions.Early steps in avian reovirus morphogenesis.Response of Three Different Viruses to Interferon Priming and Dithiothreitol Treatment of Avian Cells.VP2, VP7, and NS1 proteins of bluetongue virus targeted in avian reovirus muNS-Mi microspheres elicit a protective immune response in IFNAR(-/-) mice.Possible involvement of the double-stranded RNA-binding core protein sigmaA in the resistance of avian reovirus to interferon.Avian reovirus sigmaA localizes to the nucleolus and enters the nucleus by a nonclassical energy- and carrier-independent pathwayProtein architecture of avian reovirus S1133 and identification of the cell attachment protein.Protein coding assignment of avian reovirus strain S1133.Avian reovirus S1133 can replicate in mouse L cells: effect of pH and cell attachment status on viral infection.Microspheres-prime/rMVA-boost vaccination enhances humoral and cellular immune response in IFNAR(-/-) mice conferring protection against serotypes 1 and 4 of bluetongue virus.Interferon induction by avian reovirus.The second open reading frame of the avian reovirus S1 gene encodes a transcription-dependent and CRM1-independent nucleocytoplasmic shuttling protein.Using IC-Tagging Methodology for Production and Purification of Epitope-Loaded Protein Microspheres for Vaccination.Mode of sensitivity and resistance of vaccinia virus replication to interferon.Crystallization of the C-terminal globular domain of avian reovirus fibre.Characterization of the nucleic acid-binding activity of the avian reovirus non-structural protein sigma NS.Avian reovirus nonstructural protein microNS forms viroplasm-like inclusions and recruits protein sigmaNS to these structures.Avian reovirus-triggered apoptosis enhances both virus spread and the processing of the viral nonstructural muNS protein.Crystallization of the avian reovirus double-stranded RNA-binding and core protein sigmaA.A new double-stranded RNA mycovirus from Botrytis cinerea.Subunit composition and conformational stability of the oligomeric form of the avian reovirus cell-attachment protein sigmaC.Oligomerization and cell-binding properties of the avian reovirus cell-attachment protein sigmaC.Selective inhibition of viral gene expression as the mechanism of the antiviral action of PGA1 in vaccinia virus-infected cells.Effect of interferon on integrity of vaccinia virus and ribosomal RNA in infected cells.IC-tagged proteins are able to interact with each other and perform complex reactions when integrated into muNS-derived inclusions.Modification of late membrane permeability in avian reovirus-infected cells: viroporin activity of the S1-encoded nonstructural p10 protein.Avian and mammalian reoviruses use different molecular mechanisms to synthesize their {micro}NS isoforms.Evidence that avian reovirus sigmaA protein is an inhibitor of the double-stranded RNA-dependent protein kinase.Permeabilization of Mammalian Cells to Proteins: Poliovirus 2Aproas a Probe to Analyze Entry of Proteins into CellsEndogenous Enzymatic Activities of the Avian Reovirus S1133: Identification of the Viral Capping Enzyme
P50
Q27473517-4DFA31EB-DCE9-4B67-AE4A-00A7EF9D4E47Q27652209-E37F48D9-9889-4032-ABB8-A22943B68175Q28748479-1438588F-8587-4948-BC5F-2050090AFE49Q28748635-3437D016-2875-444C-B90B-FA095A2EF4B8Q30160104-A04E1068-8B66-4FB2-B9C3-1F671084520CQ33980233-8DE4FF61-38C7-42E8-87FF-CFEC4EBF0331Q36566124-E76C3FDF-044C-42B6-96AA-75A7EBA7A0A3Q38756727-BE6E8E53-060F-4446-AB39-AF13336B59CEQ38972255-A4D0D223-A04B-4C6E-8984-9EFA387903A9Q39588148-F84FE75B-540D-48B5-B2E3-0206F6F1E60EQ39819241-1C0BB5FE-7585-407E-81F0-331E98AB8E06Q39877546-F94AE95F-6D80-4909-81E1-3153CCDD527AQ40042068-B439455F-DBAA-4141-8BCB-8431B91B27EEQ40107213-78E7281F-572F-4B91-964B-9FEAD80F2030Q40283047-AD3B3EF5-6882-4FE7-9B11-FA3687477CE7Q40930897-2D9B639A-8F50-46DE-AD56-811C9B2B7551Q40976700-525D0913-CE24-4E4E-92E8-4FEE03ED78BBQ41232312-952277D4-7E5F-4A87-81C3-342C37595085Q41493602-5F7FE946-21B6-4CE1-B692-FDA14A2CDEF9Q41866427-BCC2D77F-3AEF-4B2E-B3A3-02C3912101F2Q42041655-E92170D7-B991-4FCA-8235-4FF298A3DF15Q42045536-B599D4EE-7851-499D-BAC1-FDC87B8C09B9Q42201857-F698F529-59F0-453E-942E-B00CCC395A21Q43167261-FDDE4607-FF41-431F-8519-F8CC43FF9D2BQ43814116-484FAED8-3D87-4764-A8CA-F8364F6DA922Q43830384-C5762E26-DF3E-4266-9358-AF33B8457256Q44020319-96297EDF-B99F-4408-B3E5-B0786FAC55B0Q45794733-09A25C6E-15F5-4A5C-9C9E-09988C1DBD6FQ45804448-26449FF7-9C69-4A29-A936-5D012CBB5FFDQ50528551-8964D700-A0F8-4B08-B65B-44CE3356318EQ50584889-B9473F70-0FA3-410A-BBA9-D769E9A7EABAQ53229721-53F23D4C-4B78-4BC8-A2F8-3EAF768E0794Q53928853-7388170B-815B-4E28-81D8-47D4C5B24C13Q56787230-B3E0482B-C046-4BDA-820E-253E6C23E08EQ58199187-6A321E33-E922-4B18-ADE6-5A047A4390C4
P50
description
Biochemist
@en
wetenschapper
@nl
name
Javier Benavente
@ast
Javier Benavente
@en
Javier Benavente
@es
Javier Benavente
@nl
Javier Benavente
@sl
type
label
Javier Benavente
@ast
Javier Benavente
@en
Javier Benavente
@es
Javier Benavente
@nl
Javier Benavente
@sl
prefLabel
Javier Benavente
@ast
Javier Benavente
@en
Javier Benavente
@es
Javier Benavente
@nl
Javier Benavente
@sl
P106
P21
P31
P496
0000-0003-4857-0312